VICL (Vical Labs) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: bob zagorin	11/7/2005 12:40:58 PM
	Read Replies (1) of 1972

schwab upgraded vical from hold to buy today (from c to b). report doesn't include any analyst text to speak of but here's what there is... Rationale Behind Our "B" Rating on VICL Fundamental Grade: B Current View Importance Free cash flow generation and growth Negative High Efficient management of working capital Positive High Ability to internally fund capital Positive High Earnings alignment with operating cash Neutral Low Track record of positive EPS surprises Positive Medium Valuation Grade: B Operating income relative to market valuation Negative Low Cash liquidity relative to market valuation Positive Medium Recent share purchases by informed investors Positive Medium Momentum Grade: B Recent brokerage analyst sentiment change Positive High Recent price performance vs. the market Neutral Low Recent short seller sentiment change Neutral Low Risk Grade: F Company size and stability Negative Medium

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next